MIOGYPSINA DANS LE FALUN DE PONTPOURQUEY PRES DE SAUCATS (BORDELAIS).TOBLER A.1928; ECLOGAE GEOL. HELV; CHE; 1928, VOL. 21, NUM. 0002, P. 385 A 387Miscellaneous

Pharmacovigilance et facteurs de croissance hématopoïétiques = postmarketting surveillance (pharmaco-vigilance) of hematopoietic growth factorsTOBLER, A.Médecine et hygiène. 1998, Vol 56, Num 2208, pp 997-1001, issn 0025-6749, 4 p.Article

(Compte rendu en anglais)TOBLER, A.Transcultural Psychiatric Research Review Montréal. 1983, Vol 20, Num 2, pp 141-142Article

An interleukin-8 (IL-8) cDNA clone identifies a frequent HindIII polymorphismFEY, M. F; TOBLER, A.Human genetics. 1993, Vol 91, Num 3, issn 0340-6717, p. 298Article

Pathophysiologie des cytokines hématopoïétiques = Pathophysiology of hematopoietic cytokinesTOBLER, A; NYDEGGER, U.Médecine et hygiène. 1993, Vol 51, Num 1979, pp 1328-1330, issn 0025-6749Article

Tumour heterogeneity and clonality : an old theme revisitedFEY, M. F; TOBLER, A.Annals of oncology. 1996, Vol 7, Num 2, pp 121-128, issn 0923-7534Article

Neue freistehende Telefonkabine aus Leichtmetall «Tobtel 90» = New free standing Aluminium Telephone Booth «Tobtel 90»RUPPLI, M; TOBLER, A.Technische Mitteilungen PTT. 1992, Vol 70, Num 9, pp 382-386, issn 0040-1471Article

The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1JENAL, M; BATLINER, J; REDDY, V. A et al.Leukemia. 2010, Vol 24, Num 5, pp 1073-1076, issn 0887-6924, 4 p.Article

Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemiaBETTICHER, D. C; RATSCHILLER, D; CERNY, T et al.Annals of oncology. 1998, Vol 9, Num 7, pp 721-726, issn 0923-7534Article

Post-remission therapy of adult acute myeloid leukaemia : One cycle of high-dose versus standard-dose cytarabineFOPP, M; FEY, M. F; VON FLIEDNER, V et al.Annals of oncology. 1997, Vol 8, Num 3, pp 251-257, issn 0923-7534Article

Id2 expression increases with differentiation of human myeloid cellsISHIGURO, A; SPIRIN, K. S; SHIOHARA, M et al.Blood. 1996, Vol 87, Num 12, pp 5225-5231, issn 0006-4971Article

Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disordersSCHWALLER, J; TOBLER, A; NIKLAUS, G et al.Blood. 1995, Vol 85, Num 8, pp 2182-2188, issn 0006-4971Article

The induction kinetics of IL-8 messenger RNA in HL60 cells demonstrate the participation of negative-acting genes(s)MEIER, R. W; NIKLAUS, G; FEY, M. F et al.Leukemia research. 1995, Vol 19, Num 7, pp 449-455, issn 0145-2126Article

Single institution experience with mobilization, harvesting, and reinfusion of peripheral blood stem cells in children with a solid tumor or leukemiaLEIBUNDGUT, K; HIRT, A; RIDOLFI LÜTHY, A et al.Pediatric hematology and oncology. 1994, Vol 11, Num 2, pp 215-221, issn 0888-0018Article

Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia : a pilot assessmentWERNLI, M; TICHELLI, A; PEDRAZZINI, A et al.British journal of haematology. 1994, Vol 87, Num 1, pp 39-43, issn 0007-1048Article

Randomized comparison of interferon-α with busulfant and hydroxyurea in chronic myelogenous leukemiaHEHLMANN, R; HEIMPEL, H; GEORGI, A et al.Blood. 1994, Vol 84, Num 12, pp 4064-4077, issn 0006-4971Article

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia : prolongation of survival by hydroxyureaHEHLMANN, R; HEIMPEL, H; WUSSOW, P. V et al.Blood. 1993, Vol 82, Num 2, pp 398-407, issn 0006-4971Article

Lyn, a src-like-tyrosine-specific protein kinase is expressed in HL60 cells induced to monocyte-like or granulocyte-like cellsMEIER, R. W; BIELKE, W; CHEN, T et al.Biochemical and biophysical research communications (Print). 1992, Vol 185, Num 1, pp 91-95, issn 0006-291XArticle

1α,25-dihydroxyvitamin D₃ inhibits γ-interferon synthesis by normal human peripheral blood lymphocytesREICHEL, H; KOEFFLER, H. P; TOBLER, A et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 10, pp 3385-3389, issn 0027-8424Article

Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysisPETERS, U. R; TSCHAN, M. P; KREUZER, K. A et al.Cancer research (Baltimore). 1999, Vol 59, Num 17, pp 4233-4236, issn 0008-5472Article

Expression and regulation of G₁ cell-cycle inhibitors (p16^INK4A, p15^INK4B, p18^INK4C, p19^INK4D) in human acute myeloid leukemia and normal myeloid cellsSCHWALLER, J; PABST, T. H; KOEFFLER, H. P et al.Leukemia. 1997, Vol 11, Num 1, pp 54-63, issn 0887-6924Article

Clonal analysis of a B-cell lymphoma with recurrent spontaneous remissions and evolution into chronic lymphocytic leukaemiaNAGEL, S; BORISCH, B; VON ROHR, A et al.Annals of oncology. 1996, Vol 7, Num 9, pp 953-960, issn 0923-7534Article

Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemiasNAKAMAKI, T; KAWAMATA, N; TSURUOKA, N et al.British journal of haematology. 1995, Vol 91, Num 1, pp 139-149, issn 0007-1048Article

The number of circulating CD34⁺ blood cells predicts the colony-forming capacity of leukapheresis products in childrenLEIBUNDGUT, K; VON ROHR, A; BRÜLHART, K et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 1, pp 25-31, issn 0268-3369Article

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemiasBETTICHER, D. C; FEY, M. F; ZULIAN, G et al.Annals of oncology. 1994, Vol 5, Num 1, pp 57-64, issn 0923-7534Article